Sign In
Buy HUM
$349.89
+22.35 (+6.82%)
At Close: Jun 04, 2026
Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit
06:52pm, Wednesday, 02'nd Nov 2022
Humana's (HUM) third-quarter earnings gain from solid premiums and membership growth within its individual Medicare Advantage business coupled with a well-performing Healthcare Services segment.
Humana Inc. (HUM) Q3 2022 Earnings Call Transcript
11:42am, Wednesday, 02'nd Nov 2022
Humana Inc. (NYSE:HUM ) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET Company Participants Lisa Stoner – Vice President-Investor Relations Bruce Broussard – President and Chief Exec
Investor Sentiment Decreases As US Stocks Fall For Second Straight Session
10:34am, Wednesday, 02'nd Nov 2022 Benzinga
The CNN Money Fear and Greed index showed some easing in overall market sentiment after US stocks recorded losses for second straight session.
Wall Street recorded sharp gains in October, with the Dow
Humana (HUM) Tops Q3 Earnings Estimates
09:02am, Wednesday, 02'nd Nov 2022
Humana (HUM) delivered earnings and revenue surprises of 10.08% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CVS Health, QUALCOMM And 3 Stocks To Watch Heading Into Wednesday
08:06am, Wednesday, 02'nd Nov 2022 Benzinga
With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects CVS Health Corporation (NYSE: CVS)
Humana beats profit expectations and affirms 2022 outlook, but revenue comes up a touch shy
06:45am, Wednesday, 02'nd Nov 2022
Shares of Humana Inc. HUM, -0.64% were indicated up fractionally in premarket trading Wednesday, after the health insurer reported third-quarter profit that beat expectations while sales came up a tou
Humana Q3 Preview: Can The Earnings Streak Continue?
06:50pm, Tuesday, 01'st Nov 2022
Humana has an impressive earnings track record, exceeding the Zacks Consensus EPS Estimate in each quarter dating all the way back to 2016.
Can Humana (HUM) Sustain Its Earnings Beat Streak in Q3?
06:04pm, Tuesday, 01'st Nov 2022
Humana's (HUM) Q3 results are expected to reflect growing premiums, attributable to its Medicare Advantage and Medicaid businesses. However, elevated marketing costs might have strained its margins.
Sanchez: this healthcare stock at an all-time high is still worth owning
03:45pm, Friday, 28'th Oct 2022
“Healthcare” has done well this year in an otherwise down market and it still has opportunities that are worth buying, says Gina Sanchez – Chief Market Strategist at Lido Advisors.
Three buys and a bail: AbbVie, Eli Lilly, Humana and Moderna
02:25pm, Friday, 28'th Oct 2022
Gina Sanchez, Lido Advisors chief market strategist, joins 'The Exchange' to discuss three stocks Sanchez is interested in buying and one the strategist is bailing on.
Best Value Stocks to Buy for October 26th
06:47am, Wednesday, 26'th Oct 2022
CBNK, TKR and HUM made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 26, 2022.
3 Top-Ranked Medical Stocks Lapping the S&P 500
04:33pm, Tuesday, 25'th Oct 2022
All three stocks are up double-digit percentages in 2022, leaving the S&P 500's performance in the dust. With the stocks carrying favorable near-term earnings outlooks, the run could easily continue.
3 Healthcare Stocks Set to Outshine Q3 Earnings Estimates
10:32am, Tuesday, 25'th Oct 2022
Recovering volumes, improved admissions, growing health awareness and wide utilization of technologies in the third quarter are expected to have aided healthcare stocks like Humana (HUM), Teladoc (TDO
Humana (HUM) Brings Affordable MA Plan to U.S. Veterans
04:34pm, Thursday, 13'th Oct 2022
Humana (HUM) ties up with USAA Life to develop a Medicare Advantage plan that transcends the VA system to fetch added healthcare benefits for veterans.
3 Blue-Chip Stocks to Boost Your Portfolio's Defense
07:33pm, Tuesday, 11'th Oct 2022
The Fed's ongoing tightening cycle, paired with geopolitical uncertainties and lingering COVID-19 restrictions, has caused many stocks to pull back significantly in 2022. However, blue-chip stocks wea
